Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Vaz, FM

Class:IdPerson:71100
_displayNameVaz, FM
_timestamp0000-00-00 00:00:00
firstnameFrederic M
initialFM
surnameVaz
(author)[LiteratureReference:71099] Molecular and Biochemical Characterization of Rat epsilon -N-Trimethyllysine Hydroxylase, the First Enzyme of Carnitine Biosynthesis.
[LiteratureReference:71105] Carnitine biosynthesis: identification of the cDNA encoding human gamma-butyrobetaine hydroxylase.
[LiteratureReference:71255] Molecular and biochemical characterization of rat gamma-trimethylaminobutyraldehyde dehydrogenase and evidence for the involvement of human aldehyde dehydrogenase 9 in carnitine biosynthesis.
[LiteratureReference:1483103] Identification and characterization of human cardiolipin synthase
[LiteratureReference:9794615] Carnitine biosynthesis in mammals
[LiteratureReference:9794623] Functional analysis of TMLH variants and definition of domains required for catalytic activity and mitochondrial targeting
[LiteratureReference:9916629] Clinical and biochemical characterization of four patients with mutations in ECHS1
[Change default viewing format]
No pathways have been reviewed or authored by Vaz, FM (71100)